Risk of Cardiovascular Disease Mortality in Patients With Diagnosed Cancer and Associated Genetic and Proteomic Mechanisms: A UK Biobank‐Based Cohort Study
Cardiovascular risk is increased in patients with cancer and may be related to altered expression of inflammation- and coagulation-related proteins. In clinical practice, it is recommended to emphasize the management of endocrine, kidney, and inflammation-related risk factors in the population with cancer.
Authors
- Shanshan Shi (ORCID: https://orcid.org/0000-0003-4970-3615)
- Jiaxi Cheng
- Yingyi Xie
- Zixiang Ye
- Wenbo Ding
- Shuang Wang (ORCID: https://orcid.org/0000-0003-0144-1484)
- Guo Yuanlin
- Yanjun Song (ORCID: https://orcid.org/0000-0001-6678-7721)
- Kefei Dou
- Yuan Du
- Sen Han
- Zhangyu Lin
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Peking University (CN)
- Peking Union Medical College Hospital (CN)
- Peking University Cancer Hospital (CN)
- Fu Wai Hospital (CN)
Publication Details
- Journal
- Journal of the American Heart Association
- Published
- 2025-12-30
- DOI
- https://doi.org/10.1161/jaha.125.044826
- Primary Topic
- Chemotherapy-induced cardiotoxicity and mitigation
- Type
- article
- Field-Weighted Citation Impact
- 0.00